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Abstract
Protease-activated receptor 2 (PAR2), a G protein-coupled receptor expressed in airway epithelia and smooth muscle, plays
an important role in airway inflammation. In this study, we demonstrated that activation of PAR2 induces mucus secretion
from the human airway gland and examined the underlying mechanism using the porcine and murine airway glands. The
mucosa with underlying submucosal glands were dissected from the cartilage of tissues, pinned with the mucosal side up at
the gas/bath solution interface of a physiological chamber, and covered with oil so that secretions from individual glands
could be visualized as spherical bubbles in the oil. Secretion rates were determined by optical monitoring of the bubble
diameter. The Ca2+-sensitive dye Fura2-AM was used to determine intracellular Ca2+ concentration ([Ca2+]i) by means of
spectrofluorometry. Stimulation of human tracheal mucosa with PAR2-activating peptide (PAR2-AP) elevated intracellular
Ca2+ and induced glandular secretion equal to approximately 30% of the carbachol response in the human airway. Porcine
gland tissue was more sensitive to PAR2-AP, and this response was dependent on Ca2+ and anion secretion. When the
mouse trachea were exposed to PAR2-AP, large amounts of secretion were observed in both wild type and DF508 cystic
fibrosis transmembrane conductance regulator mutant mice but there is no secretion from PAR-2 knock out mice. In
conclusion, PAR2-AP is an agonist for mucus secretion from the airway gland that is Ca2+-dependent and cystic fibrosis
transmembrane conductance regulator-independent.
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Introduction
Airway submucosal glands produce most of the airway mucus,
which is essential for mucociliary clearance. The submucosal gland
also secretes various antimicrobial components, such as lysozyme,
to protect the airway from bacteria [1]. Adequate mucus secretion
from airway submucosal glands is essential to maintain the airway
defense system. Defective mucus secretion may result in failure of
host defense against pathogens, which in turn could be the
underlying pathogenesis of airway infection in patients with cystic
fibrosis (CF) [2]. In contrast, overproduction of mucus secretion
from airway glands may lead to airway diseases, such as chronic
obstructive lung disease and asthma [3]. Thus, tight control of
mucus secretion is critical. Secretion from airway glands is mainly
controlled by central parasympathetic input [4]. In addition to the
autonomic nervous system, airways have abundant intrinsic
neurons and pathogen-sensing receptors, and their activation
induces mucus secretion from airway glands via a neuronal
mediator such as substance P or vasoactive intestinal peptide (VIP)
[2,5]. There is accumulating evidence supporting an important
role for these local reflexes in the airway innate immune response.
Protease-activated receptors (PARs) are G protein-coupled
receptors that are activated by proteolytic cleavage of the N-
terminal extracellular domain, leading to intracellular Ca2+
elevation [6,7]. PARs have a variety of biologic roles and are
involved in inflammatory diseases, including inflammatory bowel
disease and rheumatoid arthritis [8]. PARs are expressed in airway
epithelia [8,9] and play an important role in inflammation and
adaptive immunity by regulating functional responses of immune
cells [10]. Endogenous PAR activators such as mast cell tryptase
and neutrophil elastase induce airway inflammation and immune
responses [11], and microorganism-derived proteases such as
house dust mite allergens are also capable of activating PARs and
inducing the release of pro-inflammatory cytokines from airway
epithelial cells [12,13]. More interestingly, a bacterial protease has
been found to disable PARs and inhibit PAR-triggered signaling in
airway epithelial cells [14]. Thus, PARs are an integral component
of the airway defense system and may reveal the exact pathway by
which proteases affect innate immune responses. However, the
role of PARs in the innate immune system in the human airway
under physiological and pathophysiological conditions remains
unclear.
Among the various subtypes, PAR2 plays a major role in ion
transport and fluid secretion from airway epithelial cell cultures.
PAR2 activates the Ca2+-activated Cl2 channel (CaCC) in human
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bronchial epithelial cell lines and the mouse trachea [15]. PAR2
also induces a transepithelial current through the cystic fibrosis
transmembrane conductance regulator (CFTR) by cytosolic Ca2+
mobilization in Calu-3 cells [16,17]. Miotto et al. reported that
PAR2 is also expressed in airway glands [18]. These findings
suggest that PAR2 may regulate anion and fluid secretion in the
airway submucosal gland. In contrast to its known function in ion
transport and fluid secretion, the role of PAR2 in airway mucus
secretion remains controversial as PAR2-activating peptide
(PAR2-AP) is unable to induce mucin production in NCI-H292
cells [18] is only a weak enhancer of mucin secretion in human
bronchial epithelial cells [19]. However, until now there has been
no evidence that a PAR is involved in mucus secretion from the
airway submucosal gland. Therefore, demonstrating the role of
PAR2 in mucus secretion from the airway submucosal gland will
provide a better understanding of the host defense system in the
airway.
In this study, we show that activation of PAR2 in the human
airway gland induces mucus secretion and we dissect the
underlying mechanism in porcine and murine airway glands.
Results
PAR2-AP-induced Mucus Secretion in Human Airway
Glands
Serosal application of PAR2-AP (100 mM) to human tracheal
mucosa markedly increased glandular secretion, resulting in
bubble formation that was comparable to the response achieved
with carbachol (10 mM), a potent cholinergic agonist. Along with
the bubbles from submucosal glands, PAR2 stimulation induced
tiny bubbles which appeared to originate from the surface of the
epithelial cells (Figure 1A). A plot of mucus volume versus time for
four individual glands from a single subject is shown in Figure 1B.
PAR2-AP produced a short-latency transient peak, followed by
sustained secretion of more than 20 min. The secretion rate varied
among the glands but all the carbachol-responding glands were
also activated by PAR2-AP. Summarized data from 11 human
subjects are shown in Figure 1C. The mean secretion rate for the
first 20 min of PAR2-AP treatment (100 mM) was 1.6360.2 nl/
min, which is approximately 30% of the response achieved with
10 mM carbachol (4.9960.8 nl/min). As a next, we compared the
PAR2-AP induced secretion rate according to the level of PAR-2
expression by immunostaining. The PAR2-AP induced mucus
secretion is much bigger in tissues where the PAR-2 is expressed in
.50% of acinar cells (1.0860.5 nl/min) than in tissues the
expression is,50% of acinar cells (0.3760.6 nl/min). (Figure 1D).
PAR2-AP-induced [Ca2+]i Mobilization and the
Localization of PAR2 in the Human Airway Gland
We examined the changes in [Ca2+]i after PAR2-AP application
in dissected human airway gland cells. Because cells were found to
be more sensitive to PAR2-AP than gland tissue, only 10 mM
PAR2-AP was used. A slow increase in [Ca2+]i was evoked by
PAR2-AP within 100 sec, followed by a small sustained plateau.
Although the response was not uniform among the cells, we
observed similar responses. The peak response was approximately
40% of that seen with carbachol treatment (10 mM; Figure 2A,B).
Immunostaining for PAR2 revealed that PAR2 proteins are
expressed on the basolateral side of acinar cells of the submucosal
gland. Immunoreactivity was also noted in the cytoplasm of acinar
serous but not mucous cells (Figure 2C).
PAR2-AP-induced Mucus Secretion in the Porcine Airway
Gland
Because pig airway tissue was more readily available than
human tissue, we used pig tracheas to dissect the mechanism of
PAR2-mediated mucus secretion. We first established the dose-
response relationship for PAR2-AP in the pig airway gland using
optical methods to determine the rate of mucus secretion from
single glands. The pig gland was more sensitive to PAR2-AP than
the human airway gland as the threshold for PAR2-AP stimulation
of porcine gland mucus secretion (defined as the concentration
that produced an obvious increase in mucus secretion rates for at
least two glands in the optical field) was approximately 200 nM,
compared to 1 mM in human tissue. The EC50 was 12.98 mM, and
the approximate Vmax achieved with 100 mM PAR2-AP was
2.4760.2 nl/min/gland (n=3, 27 glands; Figure 3A). The mean
secretion rate with PAR2-AP treatment (10 mM) was 1.9260.2 nl/
min, which is approximately 40% of the response achieved with
10 mM carbachol (Figure 3B). Trypsin (10 mM), which can activate
PAR2 and possibly PAR4 [20], induced vigorous mucus secretion
at a rate of 3.3460.52 nl/min (41 glands, four pigs). However,
thrombin, an activator of PAR1, PAR3, and PAR4, did not induce
mucus secretion (Figure 3B). Mucus secretion did not decrease
with repeated exposure to PAR2-AP. However, the glandular
response to PAR2-AP was almost eliminated after trypsin
treatment (Figure 3C and D).
Lysozyme Concentration of Submucosal Gland Secretion
Mucus secretion from porcine tracheas was analyzed on
polyacrylamide gels with Coomassie Blue staining (Figure 4A).
No differences were found between PAR2AP- or carbachol-
induced mucus in either the number or intensities of the bands,
indicating that these two methods of stimulation have similar
effects on protein secretion by submucosal glands. The lysozyme
concentration in PAR2-AP-induced glandular secretion was
10.7062.42 ng/ml, similar to the concentration of lysozyme in
secretions induced by treatment with 10 mM carbachol
(10.8260.47 ng/ml, three pigs; Figure 4B).
Ca2+ and Anion Dependency of PAR2-mediated Mucus
Secretion
We compared secretory responses to PAR2-AP in the presence
or absence of a Ca2+ chelator, BAPTA-AM. BAPTA-AM (50 mM)
reduced gland secretion stimulated by PAR2-AP by approximately
50% (0.7060.08 nl/min, 21 glands, three pigs) compared with the
secretion rate measured without BAPTA-AM (1.8660.20 nl/min;
Figure 5A and B). We used bumetanide (100 mM) to block the
basolateral Na+-K+-2Cl2 cotransporter 1 (NKCC1) to reduce
luminal Cl–mediated fluid transport. In a separate experiment, we
replaced HCO3
2 in the bath with HEPES and bubbled air
through it to eliminate HCO3
–mediated fluid transport. PAR2-
AP-stimulated secretion was inhibited by both bumetanide
(0.7960.06 nl/min) and HEPES replacement (0.3560.02 nl/
min) and was nearly eliminated when these treatments were used
in combination (0.0460.02 nl/min; Figure 5B). These results
indicate that most PAR2-induced mucus secretion by submucosal
glands is dependent on Ca2+ mobilization and anion movement.
PAR2-AP-induced Mucus Secretion in PAR-2 knock out
andDF508 CFTR Mutant Mice
To examine the possible role of PAR2 and CFTR in PAR2-AP-
induced mucus secretion, we compared responses in trachea from
PAR-2 knock out and DF508 CFTR mutant mice and their wild-
type (WT) littermates. When the trachea were exposed to PAR2-
PAR2 Mediates Mucus Secretion
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AP (100 mM), large amounts of secretion were observed in
tracheas from both WT (0.1060.01 nl/min, 22 glands, four mice)
and CF mice (0.1560.01 nl/min, 15 glands, three mice), with no
significant difference between the two groups but there is no
secretion from PAR-2 knock out mice (Figure 6A and B).
Discussion
In previous studies, activation of PAR2 induces a transepithelial
anion current in tracheal epithelium, which leads to a shift from
absorption to secretion [15,21]. PAR2 activation by human airway
trypsin-like protease in NCI-H292 cells led to a small but
significant increase in mucin production, whereas PAR2-AP did
not increase mucin secretion [22]. PAR2-AP was also a weak
enhancer of mucin secretion in primary human airway epithelial
cells [19], which was believed to indicate that PAR2 is not a
significant contributor to mucus regulation. However, in the
present investigation, we directly demonstrated that PAR2
activation with a synthetic activating peptide, as well as
physiological stimulator such as trypsin, significantly induced
airway gland mucus secretion. Comparing secretion rates with
previous studies in which we used the same methods, the secretion
rate induced by PAR2-AP in the human gland was approximately
30% of that induced by carbachol treatment [23] but higher than
the responses induced by VIP [2] or substance P [5]. In addition,
tiny bubbles were observed on the airway surface after treatment
with PAR2, but the bubbles did not become bigger despite
continuous stimulation. This suggests that the main target of
PAR2 is the submucosal gland and not the airway surface
epithelium. Although PAR2 is mainly expressed in serous cells of
the airway gland, the protein content and lysozyme concentration
of PAR-2 induced mucus does not differ from that of carbachol-
induced mucus. Therefore it remains necessary to elucidate
whether PAR2-AP stimulated mucus secretion only from serous
cells or from other cells as well.
Figure 1. Serosal PAR2-AP stimulates mucus secretion from human airway submucosal glands. (A) Images of mucus bubbles formed
under oil at the orifices of single submucosal glands 15 min after PAR2-AP (100 mM) or carbachol (10 mM) stimulation. PAR2-AP also induced small
bubbles on the mucosal surface which seem to have originated from the epithelial surface inset of (A). * indicates the merging of several bubbles (*).
Scale bar: 0.5 mm. (B) Plots of secreted mucus volume over time for four individual glands are shown. Each line represents a single gland. (C)
Summary data of 52 glands from 11 subjects showing average secretion rates (6 S.E.M.) for 20-min periods following application of PAR2-AP
(100 mM) and carbachol (10 mM). Scrambled peptide did not induce mucus secretion. (D) PAR-2 AP induced mucus secretion according to the level of
PAR2 expression. * and ** indicate significant differences from the control, P,0.05 and 0.005, respectively.
doi:10.1371/journal.pone.0043188.g001
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We further dissected the underlying mechanism for PAR2-AP-
induced mucus secretion in the airway glands of pigs. Activation of
PAR2 elevated intracellular Ca2+, and PAR2-AP-induced mucus
secretion was decreased by pretreatment with a Ca2+ chelator
(BAPTA-AM). These results indicate that PAR2-mediated mucus
secretion is Ca2+-dependent. The response to PAR2-AP was not
suppressed by indomethacin (data not shown), and PAR2-AP was
still able to induce mucus secretion in the DF508 CFTR mutant
mouse. These findings are not consistent with a previous report on
research performed in Calu-3 cells [16] in which Cl2 secretion
induced by PAR2-AP was found to require prostaglandin release
and CFTR activation. Although Calu-3 cells have properties
similar to those of airway gland serous cells, their anion channel
profile is quite different from that of the airway gland tissue in vivo.
That is, the CFTR is the only anion channel in the apical
membranes of Calu-3 cells. Thus, in these cells, the apical anion
conductance is almost completely derived from CFTR channels
[24]. In contrast, both CFTR and CaCC exist in the airway
submucosal gland [23]. It is possible that the elevated cytosolic
Ca2+ induced by PAR2-AP activated the CaCC and thus induced
anion secretion in the airway gland ex vivo in our experiments.
Another discrepancy between Calu-3 cells and airway gland serous
cells is that they respond differently to repeated stimulation. Sato et
al. [17] have shown that PAR2-AP generates a brief response of
Cl2 secretion through the phosphatidylcholine-phospholipase C
(PC-PLC)-mediated pathway in Calu-3 cells, which became
desensitized by repeated PAR2-AP treatment. However, we
observed that the mucus secretion in response to PAR2-AP did
not decrease with repeated treatment in airway glands. A possible
reason for this difference is that the turnover rate for PAR2 is
more rapid in submucosal gland tissue than in cultured cells.
Although the parasympathetic pathway primarily controls
airway gland secretion, evidence increasingly supports a role for
intrinsic control systems for airway gland secretion, such as the
capsaicin-sensitive C-fiber system [5]. In our experiments,
endogenous PAR2 agonists, such as airway trypsin and neutrophil
elastase, also stimulated airway mucus secretion from the
submucosal gland. This local receptor-mediated mucus secretion
may be involved in host defense against pathogens in airway
mucosa, which is independent of parasympathetic control.
Furthermore, because the PAR2-AP-induced mucus system is
independent of the CFTR, this mechanism would be preserved in
the airways of patients with CF and could act as a salvaged route
for fluid secretion and innate immune responses. We plan to
investigate this system in CF patients.
Interestingly, PAR2 expression is increased in airway epithelial
cells in allergic airway disease [25] and in bronchial vessels of
patients with bronchitis [18]. Furthermore, human airway tryptase
(HAT) is detected in high levels in BAL fluid from patients with
chronic airway inflammatory disease [20]. Although not shown,
our recent data [26] also revealed that PAR2 expression in the
airway glands is increased in patients with allergic rhinitis. Thus,
PAR2 upregulation may represent an underlying mechanism of
mucus hypersecretion in allergic or inflammatory airway disease.
In summary, we demonstrated that PAR2-AP increases mucus
secretion from the airway glands of three different species (human,
pig, and mouse) and that this effect is Ca2+-dependent and at least
partially CFTR-independent. If PAR2 is involved in the airway
Figure 2. PAR2-AP induced [Ca2+]i changes and PAR2 expression in human airway submucosal glands. (A) Fluorescence changes in
response to 10 mM carbachol and 10 mM PAR2-AP. Cell diameters in images are approximately 20 mm. (B) [Ca2+]i vs. time for 11 cells from images in
(A), measured in response to sequential pulses of 10 mM carbachol or 10 mM PAR2-AP. Fluorescence ratio, 340 nm/380 nm. (C) Immunostaining using
PAR2 antibody showed that PAR2 is mainly expressed on the basolateral side of acinar cells. In serous glandular cells, immunoreactivity is also noted
in the cytoplasm. The negative control with mouse IgG shows no immunoreactivity. Scale bar: 50 mm.
doi:10.1371/journal.pone.0043188.g002
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host defense system, future research should focus on the potential
of this receptor as a target for therapeutic intervention.
Materials and Methods
Chemicals
Fura2-acetoxymethyl ester (fura2-AM) was purchased from
Teflabs (Austin, TX, USA). PAR2 activating peptides (PAR2-AP,
SLIGRL-NH2) and scrambled peptide (LSIGLR-NH2) were
purchased from the Korea Basic Science Institute (Seoul, Korea).
Peptide structure was confirmed by liquid chromatography/mass
spectroscopy (HP 1100 series HPLC system, Hewlett Packard,
Palo Alto, CA, USA). Trypsin, indomethacin, thrombin, bumet-
anide, and 1,2-bis(2-aminophenoxy) ethane-N,N,N,N-tetraacetic
acid-acetoxymethyl ester (BAPTA-AM) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Collagenase NB 4 was
purchased from Serva (Heidelberg, Germany).
Human Tracheal Tissue
These studies were approved by the Institutional Review Board
of Yonsei University College of Medicine (4-2010-0216), and
informed consent was obtained from all patients. Small tracheot-
omy flaps (1 cm2) were obtained from the first or second tracheal
ring after tracheotomy for airway maintenance in human patients.
The subjects (n=11) had no lung disease and their ages ranged
from 35 to 72 years (mean=59.3 years). All tissues were
transferred to ice-cold Krebs-Ringer bicarbonate buffer (KRB)
bubbled with 95% O2–5% CO2, in which they were maintained
until use, usually within 4 hr. The KRB composition was
115 mM NaCl, 2.4 mM K2HPO4, 0.4 mM KH2PO4,
25 mM NaHCO3, 1.2 mM MgCl2, 1.2 mM CaCl2, 10 mM glu-
cose, and 1.0 mM indomethacin. KRB was made to 90% volume,
and the osmolarity was measured with a Wescor 5500 vapor
pressure osmometer (Logan, UT, USA). Distilled water was added
to adjust the osmolarity to 29065 mOsm. The pH was verified to
be 7.4 (Corning Life Sciences, Lowell, MA, USA) after bubbling
with 95% O2–5% CO2.
Animals
This study was approved by the Committee on Animal
Research at Yonsei Medical Center, and all experiments with
animals were performed under appropriate guidelines. Pig
tracheas were harvested from 18 juvenile Yorkshire pigs of either
sex weighing 40–110 kg, following robotic surgery performed for
training purposes. CF model mice (n=3) containing the targeted
DF508 CFTR mutation and WT littermates (n=4) were kindly
provided by Dr. M.G. Lee (Yonsei University, Seoul, Korea).
PAR-2 knock out mice (n=4) were provided by Dr. M.H Sohn
Figure 3. Effects of PAR activators in pig airway gland. (A) Approximate dose-response relationship for mucus secretion in pig submucosal
glands. Each point represents the average of 10–14 glands from 3–4 different pig trachea. (B) Secretion rates from airway gland in response to PAR
activators. Data represent mean 6 S.E.M. secretion rates from 11 to 41 glands from two to four pigs. (C) Typical gland response to repeated PAR2-AP
application. Similar secretory responses were noted with repeated PAR2-AP treatment. (D) Trypsin (10 mM) induced vigorous mucus secretion, which
desensitized the PAR2-AP (10 mM) response.
doi:10.1371/journal.pone.0043188.g003
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(Yonsei University, Seoul, Korea). The tails were clipped at 18
days of age, and genomic DNA was isolated for subsequent
genotyping.
Optical Measurement of Mucus Secretion Rates (Mucus
Bubble Method)
To prepare tissues for optical recording of mucus secretion rates
for individual glands, a tracheal ring of approximately 1.5 cm was
cut off and opened up along the ventral midline. The mucosa with
underlying glands was dissected from the cartilage and mounted in
a 35-mm diameter Sylgard (Dow Corning Corporation, Midland
Township, MI, USA)-lined plastic Petri dish with the serosa in the
bath (,1-ml volume of KRB solution) and the mucosa exposed to
the air (Figure 7). The tissue chamber was maintained at 35–37uC
with high humidity using either a Sensortek S-4 Peltier effect
temperature controller and spiral glass humidifier or a thermistor-
controlled warming chamber and humidifier (Medical Systems,
Greenvale, NY, USA). The tissue surface was cleaned and blotted
dry with cotton swabs and further dried with a stream of gas, after
which 20–30 ml of water-saturated mineral oil was placed on the
surface. The tissue was warmed to 37uC at a rate of approximately
1.5uC/min and continuously superfused with warmed, humidified
95% O2–5% CO2. Pharmacological agents were diluted to final
concentrations with warmed, gassed bath solution, and added to
the serosal side of the tissue by complete bath replacement.
Bubbles of mucus within the oil layer were visualized by oblique
illumination, and digital images were captured with either the
macro mode of a Nikon digital camera (Tokyo, Japan) or by
mating a digital camera to one ocular of a Wild stereomicroscope.
Each image contained an internal reference grid to compensate for
any minor adjustments in magnification made during the
experiment. Stored images were analyzed either by direct
measurement or with ImageJ software (http://rsb.info.nih.gov/
ij/). Mucus volumes were calculated from the size of the spherical
bubbles and are given as nl/min/gland. Bubbles that were not
approximately spherical were omitted from secretion rate analyses.
This procedure was performed as described previously [27].
Measurement of [Ca2+]i
Human airway submucosal gland tissues (n = 3) were dissected
from tracheotomy flaps, and the tissues were further dissected
using collagenase NB4 (Serva, Heidelberg, Germany). The
isolated submucosal glands were seeded onto poly-L-lysine (Sigma,
St. Louis, MO, USA)-coated glass coverslips (22622 mm) in 35-
mm dishes and cultured for 2 days. Cells were incubated for 1 hr
in physiological salt solution (PSS) containing 5 mM fura2-AM in
the presence of Pluronic F-127 (Invitrogen, Carlsbad, CA, USA) to
enhance dye loading. Fura2-AM-loaded cells were mounted on
the stage of an inverted microscope (Nikon) for imaging. The cells
were illuminated with light of wavelengths 340 nm and 380 nm,
and the emitted fluorescent images at 510 nm were collected with
a CCD camera and analyzed using the MetaFluor system
(Universal Imaging Co., Downingtown, PA, USA). The fluores-
cence ratio (340/380) was taken as a measure of [Ca2+]i, and
fluorescence images were obtained at 3-sec intervals.
Immunostaining and Evaluation of PAR2 Staining
Tracheal mucosa harvested during tracheotomies in patients
with intracranial hemorrhage were fixed with 10% formaldehyde
solution for 24 h and then dehydrated and embedded in paraffin.
Paraffin blocks were sectioned into 4-mm-thick slices. After
deparaffinizing and rehydrating, slides were incubated in antigen
Figure 5. Ca2+ and anion dependency of PAR2-AP-induced mucus secretion in pig airway glands. (A) Images of mucus bubbles with and
without BAPTA-AM (50 mM). Scale bar: 0.5 mm. (B) Summary data from 21 to 33 glands from three pigs. Data represent mean 6 S.E.M. mucus
secretion rates. * and ** indicate significant differences from the response seen with PAR2-AP alone, P,0.05 and 0.005, respectively.
doi:10.1371/journal.pone.0043188.g005
Figure 4. Protein analyses for mucus secretion from porcine
airway gland. (A) Coomassie Blue-stained protein bands on a Tris-
glycine 4–20% gradient SDS polyacrylamide gel. Mucus secretion was
stimulated either by 10 mM PAR2-AP or 10 mM carbachol (CCh). Protein
molecular weight standards are shown on the left. (B) Lysozyme
concentration in PAR2-AP (10 mM) and carbachol (10 mM)-stimulated
mucus from three pigs.
doi:10.1371/journal.pone.0043188.g004
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Figure 7. Experimental set-up for measuring mucus secretion from airway gland. (A) A piece of trachea was harvested, cut down the
ventral midline and spread out. (B) The cartilage was removed carefully without damaging the submucosal glands. (C) After the tissue was placed so
that the luminal surface faced the O2-saturated air and the basolateral surface was immersed in KRB solution, the mucosal surface was covered with
water-saturated oil.
doi:10.1371/journal.pone.0043188.g007
Figure 6. PAR2-AP-induced mucus secretion in mice. (A) Images of mucus bubbles in the tracheas of wild type littermates, PAR-2 knock out
and targeted DF508 CFTR mutant mice 10 min after PAR2-AP stimulation. Scale bar: 0.5 mm. (B) Secretion rates in response to PAR2-AP (100 mM) or
carbachol (10 mM) in mouse tracheal glands. Data represent mean 6 S.E.M. secretion rates from four to eight mice.
doi:10.1371/journal.pone.0043188.g006
PAR2 Mediates Mucus Secretion
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retrieval solution (Tris-EDTA, pH 9.0) for 20 min at 95–100uC.
To block endogenous peroxidase, slides were treated with 0.3%
H2O2 for 15 min at room temperature. Slides were blocked in
10% normal serum with 1% BSA in TBS for 2 h at room
temperature and then incubated overnight at 4uC with a
monoclonal mouse antibody against human PAR2 (1:100, Santa
Cruz Biotechnology, Santa Cruz, CA, USA). The slides were then
incubated with horseradish peroxidase-conjugated goat anti-
mouse IgG (1:200; Jackson ImmunoResearch Laboratories, West
Grove, PA, USA) in antibody diluent solution (DAKO, Glostrup,
Denmark) for 1 hr at room temperature. Slides were developed
with DAB (DAKO) at room temperature and counterstained with
hematoxylin (Merck KGaA, Darmstadt, Germany).
The extent of the PAR-2 staining, defined as the percentage of
positive acinar staining areas, were calculated by manually tracing
out the total acinar cell area and PAR-2 positive staining area at
400X magnification using Image J software (http://rsb.info.nih.
gov/ij/).
Coomassie Blue Staining
After application of PAR2AP (10 mM) or Carbachol (10 mM),
secreted mucus bubbles were collected by using fine forcep and
micro pipette without approaching the epithelium of porcine
trachea tissue. Collected mucus were stored at 220uC until use.
Oil were removed by centrifugation at 14,000 rpm for 5 min, then
add lysis buffer with complete protease inhibitor mixture (Roche
Applied Science). After lysis, cleared lysates (30 mg of protein) were
separated by 4–20% pre-made gradient SDS-PAGE, then
stainined by using coomassie brilliant blue R-250 (sigma) solution.
ELISA for Lysozyme
Lysozyme level was measured by sandwich enzyme-linked
immunosorbent assay (ELISA) (ALPO Diagnostics, Windham,
NH). PAR2AP - or Carbachol – stimulated mucus secretion was
assayed in duplicate. After appropriate dilution, each sample was
carried out as the manufacturer’s direction. Briefly, microtiter
strips were washed five times with wash buffer, then add 100 ml of
standard, sample, controls in duplicate into respective well. The
plate was incubated for 1 hr at room temperature on horizontal
mixer. After 5 times washes, 100 ml of conjugate (peroxidase–
labeled rabbit– anti–lysozyme) was added into each well and then
incubated for 1 hr at room temperature. After 5 times washes, the
plate was incubated with the 100 ml of 3,3_,5,5_-tetramethylben-
zidine (TMB) substrate for 20 min at room temperature in the
dark. Absorbance at 450 nm was recorded using an automated
ELISA microplate reader (Molecular Devices).
Statistical Analysis
Data shown are means 6 SEM, and the Student t-test for
unpaired data was used to compare the means of different
treatment groups unless otherwise indicated. The difference
between two means was considered to be significant when
P,0.05. Curves were fit with Origin software (OriginLab
Corporation, Northampton, MA, USA) using a sigmoid function.
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